Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5A7B

Structure of the p53 cancer Y220C bound to the stabilizing small molecule PhiKan5211

Summary for 5A7B
Entry DOI10.2210/pdb5a7b/pdb
DescriptorCELLULAR TUMOR ANTIGEN P53, ZINC ION, 2-[[4-(diethylamino)piperidin-1-yl]methyl]-6-ethynyl-4-(3-phenoxyprop-1-ynyl)phenol, ... (4 entities in total)
Functional Keywordsantitumor protein, cancer, tumor suppression, ethynyl, dna binding, cancer therapy, small molecule stabilizers, molecular chaperone
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains2
Total formula weight50025.55
Authors
Joerger, A.C. (deposition date: 2015-07-03, release date: 2015-09-30, Last modification date: 2024-01-10)
Primary citationWilcken, R.,Zimmermann, M.O.,Bauer, M.R.,Rutherford, T.J.,Fersht, A.R.,Joerger, A.C.,Boeckler, F.M.
Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere.
Acs Chem.Biol., 10:2725-, 2015
Cited by
PubMed Abstract: Bioisosteric replacements are widely used in medicinal chemistry to improve physicochemical and ADME properties of molecules while retaining or improving affinity. Here, using the p53 cancer mutant Y220C as a test case, we investigate both computationally and experimentally whether an ethynyl moiety is a suitable bioisostere to replace iodine in ligands that form halogen bonds with the protein backbone. This bioisosteric transformation is synthetically feasible via Sonogashira cross-coupling. In our test case of a particularly strong halogen bond, replacement of the iodine with an ethynyl group resulted in a 13-fold affinity loss. High-resolution crystal structures of the two analogues in complex with the p53-Y220C mutant enabled us to correlate the different affinities with particular features of the binding site and subtle changes in ligand binding mode. In addition, using QM calculations and analyzing the PDB, we provide general guidelines for identifying cases where such a transformation is likely to improve ligand recognition.
PubMed: 26378745
DOI: 10.1021/ACSCHEMBIO.5B00515
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.4 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon